Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2171-2178

  Shih, P Betty ^a   Manzi, Susan ^b   Shaw, Penny ^b   Kenney, Margaret ^a   Kao, Amy H ^b   Bontempo, Franklin ^b   Barmada, M Michael ^a   Kammerer, Candace ^a   Kamboh, M Ilyas ^a,c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

C reactive protein; Genes; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; C-REACTIVE PROTEIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 56449119613     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080262     Document Type: Article

References (54)

1. Kyttaris VC, Katsiari CG, Juang Y-T, Tsokos GC. New insights into the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep 2005;7:469-75.
2. Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 1975;59:533-52.
3. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al; Grupo Latinoamericano de Estudio del Lupus Eritematoso. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138-47.
4. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987;14:913-21.
5. Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004;16:513-21.
6. Johanneson B, Lima G, von Salome J, Alarcon-Segovia D, Alarcon-Riquelme ME: Collaborative Group on the Genetics of SLE and Sjögren's Syndrome. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet 2002;71:1060-71.
7. Mohan C, Alas E, Morel L, Yang P, Wakeland EK. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to h2a/h2b/DNA subnucleosomes. J Clin Invest 1998;101:1362-72.
8. Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African American pedigrees. Proc Natl Acad Sci USA 1998;95:14869-74.
9. Tsao BP, Cantor RM, Grossman JM, et al. Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2002;46:2928-36.
10. Scofield RH, Bruner GR, Kelly JA, et al. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 2003;101:992-7.
11. Kushner I. The acute phase response: An overview. Methods Enzymol 1988;163:373-83.
12. Robey FA, Jones KD, Tanaka T, Liu TY. Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J Biol Chem 1984;259:7311-6.
13. Du Clos TW, Zlock LT, Rubin RL. Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 1988;141:4266-70.
14. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity. J Exp Med 2000;192:1353-64.
15. Szalai AJ. C-reactive protein (CRP) and autoimmune disease: Facts and conjectures. Clin Dev Immunol 2004;11:221-6.
16. Kravitz MS, Pitashny M, Shoenfeld Y. Protective molecules - C-reactive protein (CRP), serum amyloid p (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein a1 (Apo a1), and their autoantibodies: Prevalence and clinical significance in autoimmunity. J Clin Immunol 2005;25:582-91.
17. Szalai AJ, Weaver CT, McCrory MA, et al. Delayed lupus onset in (NZB x NZW)f1 mice expressing a human C-reactive protein transgene. Arthritis Rheum 2003;48:1602-11.
18. Rodriguez W, Mold C, Marnell LL, et al. Prevention and reversal of nephritis in mrl/lpr mice with a single injection of C-reactive protein. Arthritis Rheum 2006;54:325-35.
19. Maury CP, Wegelius O. Clinical value of serum amyloid and C-reactive protein measurements in secondary amyloidosis. Int J Tissue React 1985;7:405-7.
20. Becker GJ, Waldburger M, Hughes GR, Pepys MB. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980;39:50-2.
21. Morrow WJ, Isenberg DA, Parry HF, Snaith ML. C-reactive protein in sera from patients with systemic lupus erythematosus. J Rheumatol 1981;8:599-604.
22. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250-6.
23. Roy S, Tan KT. Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: Always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels. Rheumatology Oxford 2001;40:349-50.
24. Inoue T, Kanayama Y, Katoh N, et al. Significance of C-reactive protein elevation in the pretreatment stage of systemic lupus erythematosus. Scand J Rheumatol 1981;10:222-4.
25. Linares LF, Gomez-Reino JJ, Carreira PE, Morillas L, Ibero I. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin Rheumatol 1986;5:66-9.
26. Hind CR, Ng SC, Feng PH, Pepys MB. Serum C-reactive protein measurement in the detection of intercurrent infection in oriental patients with systemic lupus erythematosus. Ann Rheum Dis 1985;44:260-1.
27. Bertouch JV, Roberts-Thompson PJ, Feng PH, Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis 1983;42:655-8.
28. Barnes EV, Narain S, Naranjo A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: Relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 2005;14:576-82.
29. Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004;13:137-47.
30. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
31. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
32. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001;37:1075-82.
33. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8.
34. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the cardiovascular health study. Clin Chem 1995;41:264-70.
35. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
36. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
37. Lewontin RC. The interaction of selection and linkage. II. Optimum models. Genetics 1964;50:757-82.
38. Terwilliger JD, Ott J. Handbook of human genetic linkage. Baltimore: Johns Hopkins University Press; 1994.
39. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
40. Ott J, Rabinowitz D. The effect of marker heterozygosity on the power to detect linkage disequilibrium. Genetics 1997;147:927-30.
41. Davidson S. Research suggests importance of haplotypes over SNPs. Nat Biotechnol 2000;18:1134-5.
42. Szalai AJ, Wu J, Lange EM, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 2005;83:440-7.
43. Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005;77:64-77.
44. Miller DT, Zee RYL, Suk Danik J, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005;69:623-38.
45. Lange LA, Carlson CS, Hindorff LA, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006;296:2703-11.
46. Wessel J, Moratorio G, Rao F, et al. C reactive protein, an "intermediate phenotype" for inflammation: Human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/β-adrenergic pathway loci. J Hypertension 2007;25:329-43.
47. Asanuma Y, Chung CP, Oeser A, et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: Relationship to cardiovascular risk factors. J Rheumatol 2006;33:539-45.
48. Williams RC Jr, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 2005;32:454-61.
49. Karassa FB, Trikalinos TA, Ioannidis JPA. The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother 2004;58:286-91.
50. Clynes R, Calvani N, Croker BP, Richards HB. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clin Exp Immunol 2005;141:230-7.
51. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol 2002;169:7019-25.
52. Bodman-Smith KB, Gregory RE, Harrison PT, Raynes JG. FcγRIIA expression with FcγRI results in C-reactive protein- and IgG-mediated phagocytosis. J Leukoc Biol 2004;75:1029-35.
53. Zuniga R, Markowitz GS, Arkachaisri T, Imperatore EA, D'Agati VD, Salmon JE. Identification of IgG subclasses and C-reactive protein in lupus nephritis: The relationship between the composition of immune deposits and Fcγ receptor type IIA alleles. Arthritis Rheum 2003;48:460-70.
54. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.